PNC Financial Services Group
BMY.RT

PNC Financial Services Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

PNC Financial Services Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-106,547
Closed -$74K – 4296
2020
Q4 		$74K Sell
106,547
-8,703
-8% -$18.5K ﹤0.01% 2682
2020
Q3 		$259K Sell
115,250
-27,430
-19% -$78.3K ﹤0.01% 1782
2020
Q2 		$510K Sell
142,680
-20,725
-13% -$74.8K ﹤0.01% 1375
2020
Q1 		$620K Sell
163,405
-87,457
-35% -$288K ﹤0.01% 1177
2019
Q4 		$756K Buy
+250,862
New +$652K ﹤0.01% 1228

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

PNC Financial Services Group's BMY.RT Position: Q1 2021 in Review

PNC Financial Services Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 106,547 shares — an estimated $74K sold.

PNC Financial Services Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $756K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • PNC Financial Services Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 106,547 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $74K.
  • PNC Financial Services Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • PNC Financial Services Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $756K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on PNC Financial Services Group's 13F filing for Q1 2021, filed 7 May 2021.